NIH: Modified HIV Drug Reverses Vision Loss and Paralysis in Multiple Sclerosis Model
September 24, 2026
September 24, 2026
WASHINGTON, Sept. 24 (TNSjou) -- The U.S. Department of Health and Human Services National Institutes of Health issued the following news release:
* * *
September 23, 2026
Modified HIV drug reverses vision loss and paralysis in multiple sclerosis model
A new National Institutes of Health (NIH)-funded study indicates that the experimental drug kamuvudine-9 (K-9) facilitates recovery from pre-existing vision loss and paralysis in animal models of . . .
* * *
September 23, 2026
Modified HIV drug reverses vision loss and paralysis in multiple sclerosis model
A new National Institutes of Health (NIH)-funded study indicates that the experimental drug kamuvudine-9 (K-9) facilitates recovery from pre-existing vision loss and paralysis in animal models of . . .